Anthony Doyle Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Anthony Doyle is Chief Financial Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 266,744 shares of BCRX, which is worth approximately $2.14 Million. The most recent transaction as insider was on May 14, 2024, when has been sold 36,300 shares (Common Stock) at a price of $5.57 per share, resulting in proceeds of $202,191. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K

0% 3M change

34.74% 12M change

Total Value Held $2.14 Million

Anthony Doyle Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 14 2024	BUY Open market or private purchase	$202,191 $5.57 p/Share	36,300 Added 11.98%	266,744 Common Stock
Dec 19 2023	SELL Payment of exercise price or tax liability	$15,016 $6.05 p/Share	2,482 Reduced 1.08%	227,444 Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$35,204 $6.43 p/Share	5,475 Reduced 2.33%	229,926 Common Stock
Dec 14 2023	BUY Grant, award, or other acquisition	-	34,000 Added 12.62%	235,401 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	34,000 Added 14.66%	197,966 Common Stock
Dec 15 2022	SELL Open market or private sale	$62,130 $10.9 p/Share	5,700 Reduced 3.36%	163,966 Common Stock
Dec 14 2021	BUY Grant, award, or other acquisition	-	115,000 Added 35.52%	208,719 Common Stock
Nov 23 2021	BUY Open market or private purchase	$440,020 $12.48 p/Share	35,258 Added 27.34%	93,719 Common Stock

Anthony Doyle

Chief Financial Officer

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account